Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Montreal-area escape room named best in the world

February 26, 2026

Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

February 26, 2026

Purpose Brands Announces Plans for Orangetheory Fitness Expansion in Japan

February 26, 2026

VTGN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026

February 26, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront

February 26, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » TCPC INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds BlackRock TCP Capital Investors of the Securities Class Action Lawsuit Deadline on April 6, 2026
Press Release

TCPC INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds BlackRock TCP Capital Investors of the Securities Class Action Lawsuit Deadline on April 6, 2026

By News RoomFebruary 26, 20264 Mins Read
TCPC INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds BlackRock TCP Capital Investors of the Securities Class Action Lawsuit Deadline on April 6, 2026
Share
Facebook Twitter LinkedIn Pinterest Email
TCPC INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds BlackRock TCP Capital Investors of the Securities Class Action Lawsuit Deadline on April 6, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In BlackRock TCP To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in BlackRock TCP between November 6, 2024 and January 23, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BlackRock TCP Capital Corp. (“BlackRock TCP” or the “Company”) (NASDAQ: TCPC) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company’s investments were not being timely and/or appropriately valued; (2) the Company’s efforts at portfolio restructuring were not effectively resolving challenged credits or improving the quality of the portfolio; (3) as a result, the Company’s unrealized losses were understated; (4) as a result, the Company’s NAV was overstated; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

On February 27, 2025, before the market opened, the Company issued a press release announcing financial results for the fourth quarter and year ended December 31, 2024. The press release disclosed that the Company’s portfolio had significantly weakened during the 2024 fiscal year. Specifically, the press release revealed the number of portfolio companies on non-accrual status had more than doubled, and as a result, debt investments on non-accrual status at cost increased by 289% (from 3.7% to 14.4% of the portfolio). Moreover, the press release revealed that the Company’s net asset value (“NAV”) had fallen 22.44% year over year to $9.23 per share. Total losses, both realized and unrealized, were revealed to have ballooned to $194,895,042 for the fiscal year, a 186% increase year over year, in large part due to a newly added $72.3 million net unrealized loss within the fourth quarter. Despite this, the press release alleged the NAV of the Company was accurate at $9.23 per share, and that “the vast majority of [the Company’s] portfolio continued to perform well,” and the Company was “working closely with [its] borrowers and sponsors to resolve the portfolio issues.”

On this news, the Company’s stock price fell $0.90, or 9.64%, to close at $8.44 per share on February 27, 2025, on unusually heavy trading volume.

On January 23, 2026, after market hours, BlackRock TCP disclosed certain fourth quarter and full year 2025 financial results, including that the Company’s NAV per share as of December 31, 2025 was in fact in the range of $7.05 to $7.09, 19% less than reported the prior quarter and 23.4% less than reported the prior year.

On this news, BlackRock TCP’s stock price fell $0.76, or 12.97%, to close at $5.10 per share on January 26, 2026, on unusually heavy trading volume.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.  

Faruqi & Faruqi, LLP also encourages anyone with information regarding BlackRock TCP’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the BlackRock TCP class action, go to www.faruqilaw.com/TCPC or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7f60c456-51b6-4096-a862-d5d3beda6cc5

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

Purpose Brands Announces Plans for Orangetheory Fitness Expansion in Japan

VTGN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront

FRMI INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Fermi Investors of Securities Class Action Deadline on March 6, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

PSFE INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Paysafe (PSFE) Investors of Securities Class Action Deadline on April 7, 2026

BYND INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Beyond Meat Investors of the Securities Class Action Lawsuit Deadline on March 24, 2026

Gloria Trevi Los Angeles Concert – “Gloria Trevi: Live from BMO Stadium” – to Be VEEPS Live Pay-Per-View on Saturday, February 28

Editors Picks

Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

February 26, 2026

Purpose Brands Announces Plans for Orangetheory Fitness Expansion in Japan

February 26, 2026

VTGN INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026

February 26, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Wealthfront

February 26, 2026

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Lenovo leak reveals a foldable gaming handheld that’s also a Windows laptop

February 26, 2026

FRMI INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Fermi Investors of Securities Class Action Deadline on March 6, 2026

February 26, 2026

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics

February 26, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version